Century Therapeutics (IPSC) Beats Q4 Earnings Estimates by $0.04
Century Therapeutics (NASDAQ:IPSC) reported quarterly earnings results on March 12, 2026 that exceeded analyst expectations. The Healthcare company reported earnings per share of…
Read more
